Fount of Information

TriLink BioTechnologies社 Are you sciencing using CleanCap technology?





...You’ll confidently publish with CleanCap® technology. In fact, more than 700 publications, across a number of therapeutic areas, and in high-impact journals, cite CleanCap reagent. Here are just a few examples of how CleanCap is helping researchers move their mRNA-based therapeutic one step closer to the clinic.


Researchers at Thomas Jefferson University demonstrate that LNP-mRNA vaccines elicit memory CD8 T cells in a mouse model of smallpox to protect from lethal viral challenge. Paper1.png


Paper2.png Walter Reed Army Institute of Research designs an mRNA vaccine against malaria based on an immunodominant Plasmodium falciparum coat protein that shows sterilizing immunity in mice.


Researchers at Beam Therapeutics design a set of novel IBEs to increase the breadth of potential base-editing targets and the editing precision of a sickle cell disease mutation in patient-derived hematopoietic stem cells. Paper3.png


Paper4.png BioNTech presents data showing antibody and T cell responses after vaccination with BNT162b1 from a second, non-randomized open-label phase I/II trial.



Fount of Information は、新商品、新規取扱メーカーなどの情報をいち早く紹介するコンテンツです。情報発信のスピードを重視しているコンテンツのため、現時点で法規制や取り扱いを確認できていない商品、定価を設定できていない商品があります。ご要望やご照会を受けた商品について、法令整備や在庫の充実を図ります。